Identification of the microglia-associated signature in experimental autoimmune encephalomyelitis

Identification of the microglia-associated signature in experimental autoimmune encephalomyelitis

BackgroundMultiple sclerosis (MS) is a chronic neuroinflammatory disorder characterized by demyelination and immune dysregulation, and microglia play a central role in disease progression. Despite this, the specific microglial gene signatures contributing to MS remain inadequately characterized.Meth...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yan Wu, Jianhong Wang, Bo Chen, Yuxue Guo, Ping Gan, Yanbing Han
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-06-01
Series:	Frontiers in Immunology
Subjects:	RNA sequencing microglia multiple sclerosis (MS) experimental autoimmune encephalomyelitis (EAE) machine learning (ML)
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1581878/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Pharmacological Inhibition of Microglial Proliferation Supports Blood–Brain Barrier Integrity in Experimental Autoimmune Encephalomyelitis
by: Nozha Borjini, et al.
Published: (2025-03-01)

Investigating mechanisms underlying the development of paralysis symptom in a model of MS
by: Shruti Gupta, et al.
Published: (2025-04-01)

IL-37 suppresses CNS autoimmunity by increasing the frequency of Treg cells and reducing CD4 + T cell-derived IL-10 production
by: Reza Yazdani, et al.
Published: (2024-11-01)

Pidotimod alleviated experimental autoimmune encephalomyelitis by regulating the balance of splenic lymphocytes
by: Yanping Wang, et al.
Published: (2025-07-01)

NEK2 regulates B cell function and the severity of experimental autoimmune encephalomyelitis
by: Si-Ting Wu, et al.
Published: (2025-06-01)

Human microbiome-derived peptide affects the development of experimental autoimmune encephalomyelitis via molecular mimicryResearch in context
by: Xin Ma, et al.
Published: (2025-01-01)

Experimental autoimmune encephalomyelitis causes skeletal muscle dysfunction in mice
by: Julian Boesch, et al.
Published: (2025-04-01)

Early Synapse-Specific Alterations of Photoreceptor Mitochondria in the EAE Mouse Model of Multiple Sclerosis
by: Dalia R. Ibrahim, et al.
Published: (2025-01-01)

Irisin restrains neuroinflammation in mouse experimental autoimmune encephalomyelitis via regulating microglia activation
by: Qiu-Xia Zhang, et al.
Published: (2025-04-01)

Chemokines as therapeutic targets for multiple sclerosis: a spatial and chronological perspective
by: Nagisa Nakata Arimitsu, et al.
Published: (2025-03-01)

Lysate of Parabacteroides distasonis prevents severe forms of experimental autoimmune encephalomyelitis by modulating the priming of T cell response
by: Zuzana Jiraskova Zakostelska, et al.
Published: (2024-12-01)

RiboTag-based RNA profiling uncovers oligodendroglial lineage-specific inflammation in autoimmune encephalomyelitis: implications for pathogenesis
by: Yuhang Wang, et al.
Published: (2025-05-01)

TIA1‐Mediated Stress Granules Promote the Neuroinflammation and Demyelination in Experimental Autoimmune Encephalomyelitis through Upregulating IL‐31RA Signaling
by: Xin Hua, et al.
Published: (2025-04-01)

Theta burst stimulation promotes nestin expression in experimental autoimmune encephalomyelitis
by: Ninković Milica B., et al.
Published: (2024-01-01)

Diet modulates the therapeutic effects of dimethyl fumarate mediated by the immunometabolic neutrophil receptor HCAR2
by: Joanna Kosinska, et al.
Published: (2025-04-01)

Mechanical hypernociception in experimental autoimmune encephalomyelitis Hipernocicepção mecânica em encefalomielite autoimune experimental
by: David Henrique Rodrigues, et al.
Published: (2009-03-01)

Senescent cell reduction does not improve recovery in mice under experimental autoimmune encephalomyelitis (EAE) induced demyelination
by: Zeeba Manavi, et al.
Published: (2025-04-01)

Understanding Multiple Sclerosis Pathophysiology and Current Disease-Modifying Therapies: A Review of Unaddressed Aspects
by: Eiman M. A. Mohammed
Published: (2024-11-01)

Eugenol ameliorates uveitis in mice with experimental autoimmune encephalomyelitis through the suppression of key inflammatory genes
by: Sungmoo Hong, et al.
Published: (2024-12-01)

Short-term exposure to particulate matter triggers a selective alteration of plasma extracellular vesicle-packaged miRNAs in a mouse model of multiple sclerosis
by: Martino Bonato, et al.
Published: (2025-07-01)

Berberine promotes immunological outcomes and decreases neuroinflammation in the experimental model of multiple sclerosis through the expansion of Treg and Th2 cells
by: Maryam J. Tavaf, et al.
Published: (2023-01-01)

Therapeutic potential of agmatine in the experimental autoimmune encephalomyelitis
by: Stevanović Ivana, et al.
Published: (2021-01-01)

The role of NLRP3 inflammasome in multiple sclerosis: pathogenesis and pharmacological application
by: Wen-Gang Zhang, et al.
Published: (2025-04-01)

The contribution of BTK signaling in myeloid cells to neuroinflammation
by: Claudia Bassani, et al.
Published: (2025-06-01)

<i>Centella asiatica</i> Promotes Antioxidant Gene Expression and Mitochondrial Oxidative Respiration in Experimental Autoimmune Encephalomyelitis
by: Payel Kundu, et al.
Published: (2024-12-01)

Intranasal Administration of Extracellular Vesicles Derived from Adipose Mesenchymal Stem Cells Has Therapeutic Effect in Experimental Autoimmune Encephalomyelitis
by: Barbara Rossi, et al.
Published: (2025-07-01)

Neuroinflammation causes mitral cell dysfunction and olfactory impairment in a multiple sclerosis model
by: Charlotte Schubert, et al.
Published: (2025-03-01)

An expanded polyglutamine in ATAXIN1 results in a loss-of-function that exacerbates severity of Multiple Sclerosis in an EAE mouse model
by: Gourango Talukdar, et al.
Published: (2025-04-01)

Neutrophils, NETs and multiple sclerosis: a mini review
by: Moyuan Quan, et al.
Published: (2025-01-01)

Developing a minimally invasive gene therapy for multiple sclerosis
by: Paul J.H. Nijhuis, et al.
Published: (2025-09-01)

MSCs engineered with secreted Klotho alleviate blood–brain barrier disruption and reduce neuroinflammation more effectively than MSCs in experimental autoimmune encephalomyelitis
by: Narges Maleki, et al.
Published: (2025-07-01)

Brd4 expression in CD4 T cells and in microglia promotes neuroinflammation in experimental autoimmune encephalomyelitis
by: Anup Dey, et al.
Published: (2025-06-01)

IL-6/IL-12 superfamily of cytokines and regulatory lymphocytes play critical roles in the etiology and suppression of CNS autoimmune diseases
by: Manoj Kumar Yadav, et al.
Published: (2025-03-01)

The regulation of microglia by aging and autophagy in multiple sclerosis
by: Xiying Wang, et al.
Published: (2025-06-01)

Role of autoreactive Tc17 cells in the pathogenesis of experimental autoimmune encephalomyelitis
by: Yong Peng, et al.
Published: (2024-03-01)

Molecular dynamics simulation of wild and mutant proteasome subunit beta type 8 (PSMB8) protein: Implications for restoration of inflammation in experimental autoimmune encephalomyelitis pathogenesis
by: Shamrat Kumar Paul, et al.
Published: (2025-01-01)

Decreased Expression of the EAAT5 Glutamate Transporter at Photoreceptor Synapses in Early, Pre-Clinical Experimental Autoimmune Encephalomyelitis, a Mouse Model of Multiple Sclerosis
by: Ali El Samad, et al.
Published: (2024-11-01)

Possibilities of pharmacologic correction of cognitive disorders in conditions of experimental equivalent of multiple sclerosis
by: Nefyodov A.A., et al.
Published: (2015-06-01)

Possibilities of pharmacologic correction of cognitive disorders in conditions of experimental equivalent of multiple sclerosis.
by: A. A. Nefyodov, et al.
Published: (2015-06-01)

PD-1 Bispecific Killer Engager (PD-1 BiKE) effectively depletes effector T lymphocytes in experimental autoimmune encephalomyelitis
by: Lauren C. Naatz, et al.
Published: (2025-08-01)